{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T01:51:19Z","timestamp":1789782679593,"version":"4.0.1"},"reference-count":104,"publisher":"Cold Spring Harbor Laboratory","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cold Spring Harb Perspect Med"],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.1101\/cshperspect.a027011","type":"journal-article","created":{"date-parts":[[2016,6,8]],"date-time":"2016-06-08T02:53:18Z","timestamp":1465354398000},"page":"a027011","source":"Crossref","is-referenced-by-count":121,"title":["Rifamycins, Alone and in Combination"],"prefix":"10.1101","volume":"6","author":[{"given":"David M.","family":"Rothstein","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"246","published-online":{"date-parts":[[2016,6,7]]},"reference":[{"key":"2018091410301540000_6.7.a027011.1","doi-asserted-by":"publisher","DOI":"10.1007\/s15010-012-0325-7"},{"key":"2018091410301540000_6.7.a027011.2","doi-asserted-by":"publisher","DOI":"10.1086\/499950"},{"key":"2018091410301540000_6.7.a027011.3","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/44.1.43"},{"key":"2018091410301540000_6.7.a027011.4","doi-asserted-by":"crossref","first-page":"2590","DOI":"10.1128\/AAC.42.10.2590","article-title":"Characterization of mutations in the rpoB gene that confer rifampin resistance in Staphylococcus aureus","volume":"42","year":"1998","journal-title":"Antimicrob Agents Chemother"},{"key":"2018091410301540000_6.7.a027011.5","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00775-08"},{"key":"2018091410301540000_6.7.a027011.6","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0907893"},{"key":"2018091410301540000_6.7.a027011.7","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1128\/AAC.43.8.1866","article-title":"Physiological cost of rifampin resistance induced in vitro in Mycobacterium tuberculosis","volume":"43","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"key":"2018091410301540000_6.7.a027011.8","first-page":"1","article-title":"Impact of crystal polymorphism on the systemic bioavailability of rifaximin, an antibiotic acting locally in the gastrointestinal tract, in healthy volunteers","volume":"9","year":"2014","journal-title":"Drug Des Devel Ther"},{"key":"2018091410301540000_6.7.a027011.9","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201407-1264OC"},{"key":"2018091410301540000_6.7.a027011.10","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1179\/joc.2002.14.3.290","article-title":"Effects of rifaximin administration on the intestinal microbiota in patients with ulcerative colitis","volume":"14","year":"2002","journal-title":"J Chemother"},{"key":"2018091410301540000_6.7.a027011.11","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-200140050-00002"},{"key":"2018091410301540000_6.7.a027011.12","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200503-417OC"},{"key":"2018091410301540000_6.7.a027011.13","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00974-12"},{"key":"2018091410301540000_6.7.a027011.14","first-page":"1053","article-title":"Current use for old antibacterial agents: Polymyxins, rifamycins, and aminoglycosides","volume":"7523","year":"2009","journal-title":"Infect Dis Clin North Am"},{"key":"2018091410301540000_6.7.a027011.15","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.110.170225"},{"key":"2018091410301540000_6.7.a027011.16","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2011.02.046"},{"key":"2018091410301540000_6.7.a027011.17","doi-asserted-by":"publisher","DOI":"10.1126\/science.284.5418.1318"},{"key":"2018091410301540000_6.7.a027011.18","doi-asserted-by":"publisher","DOI":"10.1086\/596315"},{"key":"2018091410301540000_6.7.a027011.19","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00161-10"},{"key":"2018091410301540000_6.7.a027011.20","first-page":"979","article-title":"Rapid disappearance from the intestinal tract of bacteria resistant to rifaximin","volume":"12","year":"1986","journal-title":"Drugs Exp Clin Res"},{"key":"2018091410301540000_6.7.a027011.21","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2005.12.008"},{"key":"2018091410301540000_6.7.a027011.22","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/S0140-6736(89)91083-0","article-title":"Treatment of right-sided Staphylococcus aureus endocarditis in intravenous drug users with ciprofloxacin and rifampicin","volume":"334","year":"1989","journal-title":"Lancet"},{"key":"2018091410301540000_6.7.a027011.23","doi-asserted-by":"publisher","DOI":"10.1177\/1753465812452193"},{"key":"2018091410301540000_6.7.a027011.24","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.00034-09"},{"key":"2018091410301540000_6.7.a027011.25","first-page":"S231","article-title":"Studies on the treatment of tuberculosis undertaken by the British Medical Research Council tuberculosis units, 1946\u20131986, with relevant subsequent publications","volume":"3","year":"1999","journal-title":"Int J Tuberc Lung Dis"},{"key":"2018091410301540000_6.7.a027011.26","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.05552-11"},{"key":"2018091410301540000_6.7.a027011.27","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1405427"},{"key":"2018091410301540000_6.7.a027011.28","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2011.04937.x"},{"key":"2018091410301540000_6.7.a027011.29","doi-asserted-by":"publisher","DOI":"10.1038\/ja.2014.107"},{"key":"2018091410301540000_6.7.a027011.30","first-page":"542","article-title":"Evaluation of antimicrobial activity of certain combinations of antibiotics against in vitro Staphylococcus epidermidis biofilms","volume":"135","year":"2012","journal-title":"Indian J Med Res"},{"key":"2018091410301540000_6.7.a027011.31","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v17.i42.4643"},{"key":"2018091410301540000_6.7.a027011.32","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehv319"},{"key":"2018091410301540000_6.7.a027011.33","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9343(96)00070-8"},{"key":"2018091410301540000_6.7.a027011.34","doi-asserted-by":"crossref","first-page":"206","DOI":"10.2174\/1389557515666150722105705","article-title":"Understanding the molecular mechanisms of rifaximin in the treatment of gastrointestinal disorders\u2014A focus on the modulation of host tissue function","volume":"16","year":"2015","journal-title":"Mini Rev Med Chem"},{"key":"2018091410301540000_6.7.a027011.35","doi-asserted-by":"publisher","DOI":"10.1016\/0732-8893(93)90004-Q"},{"key":"2018091410301540000_6.7.a027011.36","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2014.01.026"},{"key":"2018091410301540000_6.7.a027011.37","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMcp1005750"},{"key":"2018091410301540000_6.7.a027011.38","doi-asserted-by":"publisher","DOI":"10.1111\/j.1708-8305.2012.00650.x"},{"key":"2018091410301540000_6.7.a027011.39","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00548-13"},{"key":"2018091410301540000_6.7.a027011.40","first-page":"159","article-title":"Profile of rifaximin and its potential in the treatment of irritable bowel syndrome","volume":"8","year":"2015","journal-title":"Clin Exp Gastroenterol"},{"key":"2018091410301540000_6.7.a027011.41","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1093\/jac\/dku254","article-title":"Impact of bacterial biofilm on the treatment of prosthetic joint infections","volume":"69","year":"2014","journal-title":"J Antimicrob Chemother"},{"key":"2018091410301540000_6.7.a027011.42","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.44.8.2205-2206.2000"},{"key":"2018091410301540000_6.7.a027011.43","doi-asserted-by":"publisher","DOI":"10.1136\/jcp.2009.071688"},{"key":"2018091410301540000_6.7.a027011.44","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200210-1125OC"},{"key":"2018091410301540000_6.7.a027011.45","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1314210"},{"key":"2018091410301540000_6.7.a027011.46","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00047-09"},{"key":"2018091410301540000_6.7.a027011.47","doi-asserted-by":"publisher","DOI":"10.1016\/j.anaerobe.2009.08.004"},{"key":"2018091410301540000_6.7.a027011.48","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2007.04.005"},{"key":"2018091410301540000_6.7.a027011.49","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1128\/AAC.38.2.234","article-title":"Comparative in vivo activities of rifabutin and rifapentine against Mycobacterium avium complex","volume":"38","year":"1994","journal-title":"Antimicrob Agents Chemother"},{"key":"2018091410301540000_6.7.a027011.50","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02163-12"},{"key":"2018091410301540000_6.7.a027011.51","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/22.Supplement_1.S3"},{"key":"2018091410301540000_6.7.a027011.52","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2004.04.019"},{"key":"2018091410301540000_6.7.a027011.53","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-115-9-674"},{"key":"2018091410301540000_6.7.a027011.54","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.107.121913"},{"key":"2018091410301540000_6.7.a027011.55","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.48.4.1289-1294.2004"},{"key":"2018091410301540000_6.7.a027011.56","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02420-12"},{"key":"2018091410301540000_6.7.a027011.57","doi-asserted-by":"crossref","first-page":"724","DOI":"10.5588\/ijtld.12.0083","article-title":"The chemotherapy of tuberculosis: Past, present and future","volume":"16","year":"2012","journal-title":"Tuberc Lung Dis"},{"key":"2018091410301540000_6.7.a027011.58","doi-asserted-by":"publisher","DOI":"10.1517\/14656560802694564"},{"key":"2018091410301540000_6.7.a027011.59","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2013.12.021"},{"key":"2018091410301540000_6.7.a027011.60","doi-asserted-by":"publisher","DOI":"10.1086\/508278"},{"key":"2018091410301540000_6.7.a027011.61","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.50.3.827-834.2006"},{"key":"2018091410301540000_6.7.a027011.62","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1128\/AAC.24.3.457","article-title":"Antibacterial activity of DL 473, a C3-substituted rifamycin derivative","volume":"24","year":"1983","journal-title":"Antimicrob Agents Chemother"},{"key":"2018091410301540000_6.7.a027011.63","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1843.2010.01775.x"},{"key":"2018091410301540000_6.7.a027011.64","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.157.6.1576"},{"key":"2018091410301540000_6.7.a027011.65","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00342-08"},{"key":"2018091410301540000_6.7.a027011.66","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.50.1.298-309.2006"},{"key":"2018091410301540000_6.7.a027011.67","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cis803"},{"key":"2018091410301540000_6.7.a027011.68","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s11011-013-9383-5","article-title":"Antibiotics for the treatment of hepatic encephalopathy","volume":"28","year":"2013","journal-title":"Metab Brain Dis"},{"key":"2018091410301540000_6.7.a027011.69","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02061-12"},{"key":"2018091410301540000_6.7.a027011.70","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.168.8.805"},{"key":"2018091410301540000_6.7.a027011.71","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1004409"},{"key":"2018091410301540000_6.7.a027011.72","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-011-1728-5"},{"key":"2018091410301540000_6.7.a027011.73","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2013.12.008"},{"key":"2018091410301540000_6.7.a027011.74","doi-asserted-by":"publisher","DOI":"10.1089\/mdr.2011.0010"},{"key":"2018091410301540000_6.7.a027011.75","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2006.02879.x"},{"key":"2018091410301540000_6.7.a027011.76","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2011.11.032"},{"key":"2018091410301540000_6.7.a027011.77","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/46.4.565"},{"key":"2018091410301540000_6.7.a027011.78","doi-asserted-by":"publisher","DOI":"10.1007\/s40262-014-0144-3"},{"key":"2018091410301540000_6.7.a027011.79","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2011.06.007"},{"key":"2018091410301540000_6.7.a027011.80","doi-asserted-by":"publisher","DOI":"10.1177\/2040622312472008"},{"key":"2018091410301540000_6.7.a027011.81","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.50.1.55-61.2006"},{"key":"2018091410301540000_6.7.a027011.82","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00675-11"},{"key":"2018091410301540000_6.7.a027011.83","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-85-1-82"},{"key":"2018091410301540000_6.7.a027011.84","doi-asserted-by":"publisher","DOI":"10.1086\/424506"},{"key":"2018091410301540000_6.7.a027011.85","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1007\/s40265-014-0300-y","article-title":"Rifaximin: A review of its use in reducing recurrence of overt hepatic encephalopathy episodes","volume":"74","year":"2014","journal-title":"Drugs"},{"key":"2018091410301540000_6.7.a027011.86","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.00030-10"},{"key":"2018091410301540000_6.7.a027011.87","doi-asserted-by":"publisher","DOI":"10.7326\/M14-1019"},{"key":"2018091410301540000_6.7.a027011.88","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.cld.2015.04.005","article-title":"Treatment of overt hepatic encephalopathy","volume":"19","year":"2015","journal-title":"Clin Liver Dis"},{"key":"2018091410301540000_6.7.a027011.89","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.4269\/ajtmh.2006.74.1060","article-title":"A randomized, double-blind, multicenter study of rifaximin compared with placebo and with ciprofloxacin in the treatment of travelers\u2019 diarrhea","volume":"74","year":"2006","journal-title":"Am J Trop Med Hyg"},{"key":"2018091410301540000_6.7.a027011.90","first-page":"S412","article-title":"Rifampin: Spectrum of antibacterial activity","volume":"3","year":"1983","journal-title":"Rev Infect Dis"},{"key":"2018091410301540000_6.7.a027011.91","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2009.12.017"},{"key":"2018091410301540000_6.7.a027011.92","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2010.11.004"},{"key":"2018091410301540000_6.7.a027011.93","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.jinf.2014.04.003","article-title":"Bacteraemia with rifampin-resistant Staphylococcus aureus and the potential role of cross-resistance between rifampin and rifaximin","volume":"69","year":"2014","journal-title":"J Infect"},{"key":"2018091410301540000_6.7.a027011.94","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.28.4.467"},{"key":"2018091410301540000_6.7.a027011.95","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00740-10"},{"key":"2018091410301540000_6.7.a027011.96","doi-asserted-by":"crossref","first-page":"2813","DOI":"10.1128\/AAC.43.11.2813","article-title":"Molecular characterization of rpoB mutations conferring cross-resistance to rifamycins on methicillin-resistant Staphylococcus aureus","volume":"43","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"key":"2018091410301540000_6.7.a027011.97","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.46.11.3381-3385.2002"},{"key":"2018091410301540000_6.7.a027011.98","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/162.1.96"},{"key":"2018091410301540000_6.7.a027011.99","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/14.6.1251"},{"key":"2018091410301540000_6.7.a027011.100","doi-asserted-by":"publisher","DOI":"10.1086\/516313"},{"key":"2018091410301540000_6.7.a027011.101","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkr266"},{"key":"2018091410301540000_6.7.a027011.102","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/146.4.487"},{"key":"2018091410301540000_6.7.a027011.103","doi-asserted-by":"publisher","DOI":"10.1001\/jama.279.19.1537"},{"key":"2018091410301540000_6.7.a027011.104","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra040181"}],"container-title":["Cold Spring Harbor Perspectives in Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1101\/cshperspect.a027011","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,9]],"date-time":"2019-09-09T10:44:14Z","timestamp":1568025854000},"score":1,"resource":{"primary":{"URL":"http:\/\/perspectivesinmedicine.cshlp.org\/lookup\/doi\/10.1101\/cshperspect.a027011"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6,7]]},"references-count":104,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2016,7,1]]},"published-print":{"date-parts":[[2016,7]]}},"alternative-id":["10.1101\/cshperspect.a027011"],"URL":"https:\/\/doi.org\/10.1101\/cshperspect.a027011","relation":{},"ISSN":["2157-1422"],"issn-type":[{"value":"2157-1422","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,6,7]]}}}